People with generalised anxiety disorder (GAD) often fail to achieve remission (recovering fully from their disease) despite standard treatments. This systematic review examines the efficacy and tolerability of second-generation antipsychotics (SGAs) for generalised anxiety disorder as either: augmentation therapy, i.e. using it alongside other treatments monotherapy, i.e. using it as a stand-alone treatment The reviewers [read the full story…]








